What we want to see next week from one of Jim Cramer's 6 stocks to buy

Micron is expected to report fiscal 2026 Q4 EPS of $31.49 on $50.9 billion in revenue, with investors focused primarily on the durability of AI-driven DRAM, HBM and NAND supply shortages. Shares have surged nearly 280% this year but remain more than 10% below their June record, while 95% of Street analysts hold buy-equivalent ratings. UBS sees the supply-demand gap widening into 2027 and targets $1,625 (50% implied upside); Wells Fargo expects about 40% of revenue to be supported by non-cancelable minimum-pricing strategic customer agreements, despite cutting its target to $1,400 from $1,525.

Analysis

MU is no longer trading on a simple near-term pricing beat; the key valuation variable is whether management can convert scarcity into a credible multi-quarter earnings floor without restarting the industry's historic capex overspend. The most decision-useful disclosures are HBM yield/ramp, DRAM bit-supply growth versus demand, and the share of revenue under enforceable minimum-volume or minimum-price agreements. A higher contracted mix would lower MU's cycle-beta and support multiple expansion; vague commentary on contract duration or customer concentration would leave the stock exposed to a sharp post-earnings de-rating despite strong reported results.

The second-order beneficiary of extended memory tightness is semiconductor equipment—particularly LRCX, AMAT and KLAC—if memory producers must add technically complex HBM/advanced-DRAM capacity rather than merely raise prices. That said, equipment orders are a 6-18 month consequence and can lag MU's earnings peak; an accelerated industry capex response is bullish for equipment but ultimately bearish for MU's 2027-28 pricing. NAND remains the weak link: if AI-led demand is concentrated in HBM/DRAM while enterprise storage normalizes, blended margins may disappoint even as headline memory commentary remains constructive.

Positioning is the immediate risk: near-universal bullish ratings and a large year-to-date move make an in-line guide insufficient. Over the next days, upside requires a material extension of supply tightness and disciplined capex; over 1-3 months, customer contract announcements and Semicon West commentary can validate the thesis. Falsification is management signaling DRAM supply growth above demand in calendar 2027, HBM qualification/yield slippage, weaker NAND pricing, or a capital-return plan that competes with required technology investment.

Key Decisions for Investors

• Maintain a tactical long MU only through earnings with defined downside: use a 5-7% stop or reduce into the event if implied volatility prices a move above the prior post-earnings range. Add only if guidance and contract disclosures support tightness through at least the next two quarters; target a 12-18% rerating, versus 10-15% downside on an in-line outlook.
• Prefer a 3-6 month pair trade long MU / short SOXX or SMH rather than outright broad semiconductor exposure. MU has direct pricing leverage to memory scarcity, while the hedge reduces risk from an AI-capex or rates-driven sector-wide multiple contraction; exit if management indicates supply catches demand before calendar 2027.
• For a less crowded follow-on expression, accumulate LRCX and KLAC on weakness after earnings rather than chase MU. Their upside requires confirmed incremental memory-capex budgets, so treat management commentary on wafer-fab equipment spending and HBM capacity additions as the trigger; a broad capex-discipline message invalidates the trade.
• Do not underwrite a buyback as the primary catalyst until restrictions lapse and management quantifies the authorization, timing and funding source. A large authorization funded while capex rises would be financially cosmetic; prioritize FCF after technology-node investment and net-cash trajectory over headline capital-return language.